share_log

羚锐制药(600285.SH)部分董事、监事完成减持18.61万股

Some directors and supervisors of Ling Rui Pharmaceutical (600285.SH) completed a shareholding reduction of 1861,000 shares

Zhitong Finance ·  May 24 05:31

Ling Rui Pharmaceutical (600285.SH) announced that company director Wu Xizhen and supervisor Li Jin reduced their holdings of the company by a total of 18...

Zhitong Finance App News, Ling Rui Pharmaceutical (600285.SH) announced that company director Wu Xizhen and supervisor Li Jin reduced their holdings of the company's shares by a total of 1861,000 shares, and the implementation of this holdings reduction plan has been completed.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment